Diagnostic options · UAE

Neurogenetic tests in Dubai & UAE

Compare available Neurogenetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

750.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetic test prices

Showing 1–15 of 33 matching tests.

Neurogenetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5773 AP4M1 Gene SPG50 Genetic Test This test identifies mutations in the AP4M1 gene associated with Hereditary Spastic Paraplegia type 50 (SPG50).	Peripheral whole blood (3–5 mL EDTA), dried blood spot on FTA card, or previously extracted genomic DNA	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AP4M1 gene sequence variants", "Mutations associated with SPG50"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications"] Indications ["Individuals with clinical features of hereditary spastic paraplegia", "Individuals with a confirmed family history of SPG50", "Couples planning a family where one partner carries a known AP4M1 mutation"] Measurement technique Confirm with laboratory Codes LOINC: 94482-6 ICD-10: G11.4 Clinical summary This test identifies mutations in the AP4M1 gene associated with Hereditary Spastic Paraplegia type 50 (SPG50).
TEST-5547 ARFGEF2 Gene Periventricular Heterotopia with Microcephaly Genetic Test This test identifies pathogenic variants in the ARFGEF2 gene associated with periventricular nodular heterotopia and microcephaly.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARFGEF2 gene coding region variants", "Pathogenic mutations, small indels, copy number variants"] Parameters [] Preparation ["Detailed neurological and developmental history of the patient.", "Mandatory pre-test genetic counselling session."] Indications ["Suspected periventricular nodular heterotopia", "Suspected microcephaly with neurological symptoms", "Family history of ARFGEF2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 73732-6 ICD-10: Q04.8, Q02 Clinical summary This test identifies pathogenic variants in the ARFGEF2 gene associated with periventricular nodular heterotopia and microcephaly.
TEST-4965 ATP6AP2 Gene NGS Test (X‑Linked Intellectual Disability & Epilepsy) This test evaluates the ATP6AP2 gene for pathogenic variants associated with X-linked intellectual disability and epilepsy.	Whole blood, extracted DNA, or one-drop FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP6AP2 gene sequence", "Pathogenic variants in coding regions and splice sites"] Parameters [] Preparation ["A clinical history must be documented", "A comprehensive pedigree chart must be drawn", "Pre-test genetic counselling session is mandatory", "Avoid supplements or medications that could interfere with DNA quality"] Indications ["Individuals with early-onset epilepsy and intellectual disability of unknown cause", "Carrier screening in female relatives of affected males"] Measurement technique Confirm with laboratory Codes LOINC: 79294-9 ICD-10: Z13.73 Clinical summary This test evaluates the ATP6AP2 gene for pathogenic variants associated with X-linked intellectual disability and epilepsy.
TEST-5806 ATXN8OS Gene Spinocerebellar Ataxia Type 8 Genetic Test This genetic test identifies CTG repeat expansions in the ATXN8OS gene, which are the cause of autosomal dominant spinocerebellar ataxia type 8 (SCA8).	Whole Blood (EDTA tube), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CTG repeat expansions in the ATXN8OS gene", "Allele size", "Clinical pathogenicity"] Parameters [] Preparation ["Continue prescribed medications", "Mandatory pre-test genetic counselling session", "Avoid anticoagulant medications (e.g., aspirin) for 24 hours prior if providing a dried blood spot"] Indications ["Suspected SCA8 based on clinical presentation", "Family history of SCA8", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 101370-4 ICD-10: G11.2 Clinical summary This genetic test identifies CTG repeat expansions in the ATXN8OS gene, which are the cause of autosomal dominant spinocerebellar ataxia type 8 (SCA8).
TEST-6087 CLN6 Gene Neuronal Ceroid Lipofuscinosis Type 6 (NCL6) Genetic Test This genetic test analyzes the CLN6 gene for pathogenic variants associated with Neuronal Ceroid Lipofuscinosis Type 6 (NCL6). It detects single nucleotide variants, small insertio...	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLN6 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling is mandatory"] Indications ["Suspected diagnosis of NCL6", "Family history of NCL6", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 72498-6 ICD-10: E75.4 Clinical summary This genetic test analyzes the CLN6 gene for pathogenic variants associated with Neuronal Ceroid Lipofuscinosis Type 6 (NCL6). It detects single nucleotide variants, small insertions/deletions, and copy number variants across all coding exons.
TEST-5365 DNMT1 Gene Hereditary Sensory Neuropathy Type 1E DNA Test This diagnostic test evaluates the DNMT1 gene for pathogenic variants associated with Hereditary Sensory Neuropathy Type 1E (HSAN1E).	Whole Blood (Peripheral) or FTA Card Dried Blood Spot	3–4 Weeks (express available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DNMT1 gene", "Presence of mutations linked to HSAN1E"] Parameters [{"name": "DNMT1 Gene Variants", "reference_range": "No pathogenic variants detected"}] Preparation ["No specific fasting required.", "No medication adjustments needed prior to testing."] Indications ["Clinical suspicion of Hereditary Sensory Neuropathy Type 1E (HSAN1E)", "Family history of HSAN1E", "Neurological examination findings consistent with HSAN1E"] Measurement technique Confirm with laboratory Codes LOINC: 21618-3 ICD-10: G60.8 Clinical summary This diagnostic test evaluates the DNMT1 gene for pathogenic variants associated with Hereditary Sensory Neuropathy Type 1E (HSAN1E).
TEST-5732 ERLIN2 Gene SPG18 Genetic Test This test identifies pathogenic variants within the ERLIN2 gene associated with hereditary spastic paraplegia type 18 (SPG18).	Whole Blood (EDTA) or Buccal Swab (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ERLIN2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation [] Indications ["Suspected hereditary spastic paraplegia type 18 (SPG18)", "Patients with progressive lower-limb spasticity and upper motor neuron signs"] Measurement technique Confirm with laboratory Codes LOINC: 101289-4 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants within the ERLIN2 gene associated with hereditary spastic paraplegia type 18 (SPG18).
TEST-5654 FA2H Gene SPG35 Next-Generation Sequencing (NGS) Genetic Test This test detects pathogenic variants in the FA2H gene associated with spastic paraplegia type 35 (SPG35).	Peripheral whole blood (EDTA tube, 4 mL)	3-4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FA2H gene variants", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting or special dietary preparation is necessary."] Indications ["Suspected diagnosis of spastic paraplegia type 35 (SPG35)", "Family history of SPG35"] Measurement technique Confirm with laboratory Codes LOINC: 90837-4 ICD-10: G11.4 Clinical summary This test detects pathogenic variants in the FA2H gene associated with spastic paraplegia type 35 (SPG35).
TEST-4279 FGF12 Gene Early Infantile Epileptic Encephalopathy Type 47 (EIEE47) Genetic Test This genetic test identifies pathogenic variants within the FGF12 gene associated with Early Infantile Epileptic Encephalopathy Type 47 (EIEE47).	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGF12 gene", "Single-nucleotide variants (SNVs)", "Insertions or deletions (indels)", "Copy-number changes"] Parameters [] Preparation ["No special fasting, diet, or medication pause is required before collection.", "Mandatory pre-test genetic counselling session and pedigree charting are completed before the blood draw."] Indications ["Suspected diagnosis of Early Infantile Epileptic Encephalopathy Type 47 (EIEE47)", "Neonatal-onset seizures with developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G40.4 Clinical summary This genetic test identifies pathogenic variants within the FGF12 gene associated with Early Infantile Epileptic Encephalopathy Type 47 (EIEE47).
TEST-3827 FLVCR1 Gene Posterior Column Ataxia with Retinitis Pigmentosa (PCARP) Genetic Test This genetic test analyzes the FLVCR1 gene to detect pathogenic variants associated with Posterior Column Ataxia with Retinitis Pigmentosa (PCARP).	Peripheral whole blood (EDTA), extracted DNA, or Dried Blood Spot (FTA card)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLVCR1 gene coding region", "Copy Number Variations (CNV) in FLVCR1"] Parameters [] Preparation ["No fasting required", "Continue prescribed medications unless advised otherwise by your doctor"] Indications ["Suspected diagnosis of PCARP", "Family history of PCARP", "Carrier screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94288-3 ICD-10: G11.8 Clinical summary This genetic test analyzes the FLVCR1 gene to detect pathogenic variants associated with Posterior Column Ataxia with Retinitis Pigmentosa (PCARP).
TEST-4108 GNB4 Gene CMTDIF Genetic Test This test analyzes the GNB4 gene for pathogenic variants associated with Charcot-Marie-Tooth disease, dominant intermediate type F (CMTDIF). It is the definitive diagnostic tool fo...	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic single-nucleotide variants in the GNB4 gene", "Copy-number variations (CNV) in the GNB4 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 4 weeks)"] Indications ["Suspicion of Charcot-Marie-Tooth disease, dominant intermediate type F (CMTDIF)", "Family history of CMTDIF", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81263-6 ICD-10: G60.0 Clinical summary This test analyzes the GNB4 gene for pathogenic variants associated with Charcot-Marie-Tooth disease, dominant intermediate type F (CMTDIF). It is the definitive diagnostic tool for this specific hereditary motor and sensory neuropathy.
TEST-5059 GRIA3 Gene Intellectual Disability (X‑Linked Type 94) Genetic Test This test detects pathogenic variants in the GRIA3 gene associated with X-linked intellectual disability type 94.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GRIA3 gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No specific preparation required"] Indications ["Diagnosis of X-linked intellectual disability type 94", "Family planning and recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92838-2 ICD-10: F78 Clinical summary This test detects pathogenic variants in the GRIA3 gene associated with X-linked intellectual disability type 94.
TEST-4847 GRIN1 Gene Sequencing Test This test evaluates the GRIN1 gene for pathogenic variants associated with autosomal dominant mental retardation type 8 (MRD8).	Peripheral whole blood (EDTA)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GRIN1 gene", "Copy Number Variations (CNVs) within the GRIN1 gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling required", "Pedigree chart mandatory for minors per UAE regulations", "Do not discontinue prescribed antiepileptic, neuroleptic, or psychiatric medications without consultation"] Indications ["Suspected autosomal dominant mental retardation type 8 (MRD8)", "Severe neurodevelopmental disorders", "Refractory epilepsy", "Diagnostic odyssey for intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 87673-5 ICD-10: Q99.8 Clinical summary This test evaluates the GRIN1 gene for pathogenic variants associated with autosomal dominant mental retardation type 8 (MRD8).
TEST-4184 ITM2B Gene (Familial British Dementia) Genetic Test This test evaluates the ITM2B gene for pathogenic variants associated with Familial British Dementia (FBD). It uses Next-Generation Sequencing (NGS) to analyze the entire coding re...	Peripheral whole blood (EDTA) or buccal swab	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ITM2B gene", "Copy number variations within the ITM2B gene"] Parameters [] Preparation ["No fasting required", "No special preparation required"] Indications ["Individuals with clinical symptoms suggestive of FBD", "Family members of individuals diagnosed with FBD", "Differential diagnosis of early-onset dementia"] Measurement technique Confirm with laboratory Codes LOINC: 101423-5 ICD-10: G31.09, E75.58 Clinical summary This test evaluates the ITM2B gene for pathogenic variants associated with Familial British Dementia (FBD). It uses Next-Generation Sequencing (NGS) to analyze the entire coding region and copy number variations.
TEST-5527 LRRK2 Gene (PARK8) Parkinson Disease Genetic Test This test identifies inherited mutations in the LRRK2 gene associated with an increased risk of developing Parkinson disease.	Peripheral Whole Blood (3–5 mL in EDTA tube); alternative: extracted genomic DNA (≥1 µg, ≥50 ng/µL)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LRRK2 gene mutations", "Point mutations", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Pre-test genetic counseling session is mandatory"] Indications ["Confirmed family history of Parkinson disease", "Early-onset Parkinson's symptoms", "Specific ethnic backgrounds with higher founder mutation prevalence"] Measurement technique Confirm with laboratory Codes LOINC: 95540-2 ICD-10: G20, Z13.81 Clinical summary This test identifies inherited mutations in the LRRK2 gene associated with an increased risk of developing Parkinson disease.

Category overview

Neurogenetic: overview

Pinpointing the exact hereditary cause of a progressive movement disorder, severe neuropathy, or early-onset cognitive decline is essential for unlocking the most effective neurological care available. As a highly focused diagnostic tool in our Molecular Genetics department, Neurogenetic testing specifically targets the exact DNA mutations responsible for your family's unique neurological challenges. By leveraging advanced sequencing technology, this precise genomic screening confirms conditions like inherited ataxias or early-onset Alzheimer's, providing the critical data necessary to assess carrier status, evaluate risks for future children, and safely guide tailored neurological interventions and access to precision therapies. Highly regarded for specialized diagnostic excellence among the best diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take control of your long-term brain health—schedule your neurogenetic testing in UAE, coordinate a comfortable home sample collection, or consult our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.